DJIA 18,079.40 -123.97 -0.68%
NASDAQ 4,962.68 -17.22 -0.35%
S&P 500 2,096.55 -11.23 -0.53%
market minute promo

7.08 0.30 (4.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $7.06 4.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.76
Previous Close $6.78
Daily Range $6.58 - $7.11
52-Week Range $3.10 - $7.84
Market Cap $492.5M
P/E Ratio 61.64
Dividend (Yield) $0.00 (0.0%)
Volume 532,100
Average Daily Volume 673,702
Current FY EPS $0.02

Sector

Healthcare

Industry

Drug Makers

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Actavis' Q4 Earnings to Beat Expectations, Growth Continues - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

KaloBios Pharmaceuticals' KB001-A Fails Primary Endpoint - Analyst Blog

The Biggest Risks For Stocks In 2015?

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ...

Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker Q3 2014 Results - Earnings Call Transcript

See More PGNX News...

PGNX's Top Competitors

PGNX $7.08 (4.42%)
Current stock: PGNX
AMGN $159.18 (0.39%)
Current stock: AMGN
GILD $103.36 (0.55%)
Current stock: GILD
BIIB $414.32 (0.37%)
Current stock: BIIB